Anywave Technologies

Anywave Technologies, Inc. (Beijing) was established in 2004 as a professional ophthalmic medical products company. After years of dedicated research and development in the field of ophthalmic Optical Coherence Tomography (OCT) technology, it has become one of the few global manufacturers of three-dimensional spectral-domain combined anterior and posterior OCT. Anywave’s OCT products not only fully implement the currently globally leading spectral-domain OCT technology but also integrate both anterior and posterior OCT functions into a single device, greatly enhancing the cost-performance ratio. Anywave's OCT leads the fifth generation of high-definition, high-speed OCT technology with a resolution of up to 3 microns. Anywave contributes to the popularization of OCT products and the improvement of diagnostic standards for fundus diseases. Anywave ushers in the era of semiconductor fundus lasers, offering three major series of fundus laser products (GoldeX series, Rosen series, Jader series), covering all applications of laser products in fundus treatment. Due to the company's consistent strategy of fostering creativity and enhancing product innovation, along with its commitment to improving capabilities in medical laser engineering and manufacturing, Anywave lasers have established a strong brand presence in the ophthalmic laser industry. The newly launched GoldeX series semiconductor 577nm yellow light is setting new trends in fundus laser treatment.The company engages in the research, manufacturing, sales, and service of ophthalmic medical equipment. Its products include the 5th generation high-definition, high-speed Ophthalmic Optical Coherence Tomography (OCT), which offers the highest imaging clarity among all OCT products. Additionally, its three series of fundus laser treatment devices cover all areas of fundus laser therapy, utilizing all-semiconductor lasers with several technologies leading globally.